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ABSTRACT

The intimin gene in the Locus of Enterocyte Effacement (LEE) island of pathogenicity is
the primary attachment mechanism in Citrobacter rodentium. Intimin is a bacterial adhesin
(protein) that attaches to obtain a niche/nutrient and thrive within the intestine. Intimin was
deleted within C. rodentium to study colonization and pathogenesis in the murine intestine.
Additionally, C. rodentium is an attaching/effacing pathogen, and a useful murine model
in understanding Enterohemorrhagic Escherichia coli (EHEC) infection in humans. E. coli
and C. rodentium cause gastroenteritis in humans and mice, respectively. C. rodentium is
a murine pathogen commonly used to model gastrointestinal disease because EHEC cannot
be studied within mice from its lack of pathogenicity. Results have shown that C.
rodentium uses intimin through causing disease during competition with commensal E.
coli. By studying the mechanisms and genes involved in pathogenic adhesion in C.
rodentium, it will be easier to find out a cure or treatment for illness caused by the before
mentioned E. coli strains such as Crohn’s disease, ulcerative colitis and colonic
tumorigenesis.
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Intimin Likely Used to Cause Disease During Competition with Commensal Escherichia
coli
INTRODUCTION
Citrobacter species are often present in soil and water, and can be isolated from
human and animal feces (1). Citrobacter rodentium, formerly known as Citrobacter
freundii biotype 4280 is a non-invasive, gram-negative, enteric pathogen for mice that is
similar to the human enteric pathogens, Enteropathogenic Escherichia coli (EPEC) and
Enterohemorrhagic E. coli (EHEC) (1). Both EHEC and EPEC are poorly pathogenic in
mice, yet can infect humans and other domestic animals (1). EPEC and EHEC O157:H7
are food-borne pathogens that cause diarrhea, hemolytic-uremic syndrome, and
hemorrhagic colitis (2). As a non-invasive pathogen, C. rodentium is useful to in how the
host recognizes and eliminates pathogens on the intestinal lumen, and differentiates the
pathogens from the normal flora (1). C. rodentium is a member of the family of bacterial
pathogens, and currently, the only known murine attaching and effacing (A/E) pathogen
(3). Attachment is localized to the intestinal epithelium whereas effacement of the brushborder microvilli is characterized by the formation of pedestal-like structures underneath
adherent bacterium (4, 5).
EHEC is a human pathogen that can cause attaching and effacing (A/E) lesions by
colonizing the intestinal mucosa (4). EPEC is the main cause of infantile diarrhea, and
results in high rates of illness and death in developing countries (4). C. rodentium is an
essential model organism that can colonize the host—and initiating an immune response
including an apoptotic and inflammatory response (4). In addition, C. rodentium is an
effective model for studying inflammation as a result of mucosal immune responses to
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infection (4). C. rodentium induces inflammation in the cecum and the colon (4). C.
rodentium infections in mice present the same way as other similar gastrointestinal
pathologies in mice (1).
C. rodentium is an unstable pathogen because of active rearrangements of mobile
genetic elements and because of macro-scale genomic recombination. This study showed
that genetic rearrangements caused C. rodentium to become less pathogenic because the
gene deletion connected C. rodentium with pathogenicity. This showed that C. rodentium
was the only known bacteria to cause disease in laboratory rodents. C. rodentium is also
useful in studying gastroenteritis in other animals, such as rabbits and piglets. Infection
caused by C. rodentium is useful for modeling several important intestinal disorders such
as Crohn’s disease, ulcerative colitis, and colon tumorigenesis so that mechanisms can be
studied and cures can be found (4, 6, 7).
C. rodentium DBS100 and Locus of Enterocyte Effacement (LEE)
The two studied strains of C. rodentium are ICC168 (FN543502) and DBS100
(ATCC 51459), both of which were isolated from a disease outbreak of Swiss-Webster
mice at Yale University School of Medicine in 1972 (7). DBS100 and ICC168 share a
common ancestor with the primary difference where DBS100 is used in the United States,
and ICC168 is used in Europe (7). DBS100 can induce pedestal formation in vivo (8).
Studies have shown C. rodentium might require signals from the intestinal microbiota or
from the host to regulate pathogenesis and facilitate colonization in the colon (4). The
intestinal microbiota affects the development and activity of intestinal immune cells in
mice that have increased resistance to colonization by C. rodentium (4). Additionally,
nutrient supplementation with omega-6-polyunsaturated fatty acids (PUFAs), omega-3
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PUFAs, or vitamin D regulates mucosal immune responses (4). Omega-3 PUFA and
omega-6 PUFA supplementation reduces C. rodentium-induced inflammation but impedes
epithelial intestinal alkaline phosphatase. Epithelial intestinal alkaline phosphatase
detoxifies C. rodentium lipopolysaccharide (LPS) to limit inflammation, which causes
increased mortality (4). Diet supplementation with monosaccharides provides an initial
carbon source for C. rodentium to overcome lag and consequently outcompete the
microbiota in the gastrointestinal tract (4).
Intestinal colonization by C. rodentium occurs in three stages: transient loose
attachment, translocation of bacterial effectors into the cell via Type III secretion system
(T3SS), and the formation of an A/E lesion (4). To form A/E lesions, the 41 genes of the
LEE pathogenicity island are clustered into five operons: LEE1-5. The entire LEE
pathogenicity island encodes transcript regulators ler, glrA, and glrR, the structural
components of T3SS, effectors, their individual chaperones, and the outer membrane
adhesion molecule, intimin (4). The translocation intimin receptor, Tir is considered the
best characterized T3SS effector through inserting into the plasma membrane as a hairpinloop (4).
C. rodentium Effacement
Wanyin Deng et al. conducted a study in 2001 that focused on effacement caused
by C. rodentium. EPEC and EHEC in a similar mechanism as C. rodentium, intimately
attach to host intestinal cells, which induces effacement of brush border microvilli (3). C.
rodentium’s is analogous to EPEC and EHEC with the secretion of several Esp proteins
into the smallest culture medium and translocates some of the proteins into host cells. ES
proteins are enterococcal surface proteins that aid in colonization and cause disease in
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diverse hosts including humans, dogs, rabbits, and pigs (3). The Esp proteins include Esp
A, Esp B, and Esp D (3). Esp A, Esp B and Esp D are virulence factors and three EPEC
type III secreted proteins. An intimin mutant is a bacterium that lacks the intimin gene and
consequently the protein. The E. coli, Tir gene also compliments C. rodentium (3).
Series of Infection of C. rodentium
Many gastrointestinal infection studies involve the inoculation of mice by feeding
the mice lab-cultured bacteria resulting in a highly repeatable infection cycle (4). C.
rodentium infected mice can colonize analogous to certain strains of E. coli, and cause
severe gastroenteritis in humans. J.W. Collins et al. found that during lab infection, C.
rodentium levels can reach 1-3% of the total intestinal microbiota, colonizing only in the
distal colon. In addition, the normal course of C. rodentium infection in mice is
multiplication of C. rodentium to a high level by day 7 post-infection that is cleared by day
21 (4). About two to three days later post-infection, bacteria should accumulate in the distal
colon (4). Mice that lack T cells and B cells develop chronic infection whereas normal mice
that have recovered from infection are more immune to repeated C. rodentium infection
(4).
C. rodentium is an important model organism for human gastrointestinal disease
research. C. rodentium is under the family of pathogenic bacteria that spreads via fecaloral transmission, and causes colitis, or transmissible murine crypt hyperplasia (4). C.
rodentium colonizes the major lymphoid structures in the colon first before traveling down
the gastrointestinal tract (1). C. rodentium infected mice through natural transmission can
rapidly colonize C. rodentium in the colon, and cause hyperplasia, without needing to adapt
in the cecum (1). Development of colonic hyperplasia relates to an increased susceptibility
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to carcinogens (1). The majority of mouse strains such as C57B1/6, NIH Swiss, and Balb/c
show little to no mortality when infected with C. rodentium. This explains why the CD-1
mice are used to model infection (1).
Pathogenesis and Role of Intimin in Attachment
C. rodentium shares over half of its genes with EPEC and EHEC, including the the
locus of enterocyte effacement (LEE), a pathogenicity island, which codes the proteins to
form A/E lesions (9). A main portion of LEE is the intimin gene, eae. The intimin-encoding
eae gene was sequenced originally from EPEC strain E2348/69, and later from the EHEC
strain EDL933 (10). It has been shown to have a conserved sequence across many E. coli
and Citrobacter genomes. LEE also contains genes that encode for the LEE gene
expression regulator, Ler (3). Ler is a type III secretion system (3). Schauer and Falkow
validated that intimin expressed by C. rodentium is vital for forming intestinal A/E lesions
in infected mice (11). Intimin’s role in human disease was shown in human volunteer
studies that ingested a void isogenic eae mutant of EPEC strain E2348/69 (10). The intimin
family is expanding and there is confirmation that recombination has played a role in the
history of eae (10). Further studies including pathogenetic and epidemiological
investigations are needed to explain the mechanism and role of eae variability in human
disease (10).
Intimin serves as the primary attachment mechanism in C. rodentium (8). Intimin
was the first EPEC protein identified as vital for A/E lesion formation in vitro and for full
virulence in human volunteer studies (8). C. rodentium carries intimin-β, which is essential
for attachment (8). Polymerase chain reactions (PCR) can be used to remove the intimin
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gene (eae) to help further understand how essential attachment is to colonization and
pathogenicity (9).
Studies have shown that exchanging intimin-α of EPEC with intimin-γ of EHEC
without exchanging Tir in a recombinant EPEC strain resulted in enhanced tropism to
Peyer’s patches (9). The gene intimin-α spread throughout the small intestine instead of
intimin-γ (9). The same study showed that a few intimin alleles are rare among strains
related to severe human gastrointestinal disease (9). Further pathogenic studies and
epidemiological investigations are now in progress to clarify the mechanism and the role
of eae variability in human gastrointestinal disease (9).
The Role of Tir, the Intimin Receptor
All A/E pathogens translocate their own intimin receptor, Tir (10). Tir was found
initially as a 90-kDa tyrosine-phosphorylated protein in the target cell membrane, and was
previously called Hp90 (10). Throughout the infection of C. rodentium within the colonic
epithelium, adherent bacteria translocate Tir into the infected enterocyte by a type III
secretion system (T3SS), which is further added into the plasma membrane in a hairpinloop structure (4). C. rodentium puts Tir into the membrane of the enterocyte so that intimin
can bind to it and thus allow the bacteria to adhere to the enterocyte (4). Tir is translocated
to the apical side of colonic epithelial cells (4). During murine infections, Tir is expressed
in C. rodentium, and then translocated into host intestinal epithelial cells (4). Post infection,
the bacterial count of C. rodentium can reach from 108 – 109 Colony forming units (CFUs)
per colon at day 10-14 in a few mouse strains and can be visualized through bacterial
population abundances (4). Intimin binding causes the clustering of Tir and begins to
assemble signaling complexes and actin polymerization (4).
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The central actin polymerization pathway in vitro is initiated by phosphorylation of
the tyrosine at amino acid 471 of Tir (4). This results in the formation of a binding site for
non-catalytic region tyrosine-kinase (NCK) of the mammalian adaptor protein (4). NCK
acts as an activator for the Tir-induced actin polymerization pathway at mucosal surfaces
(4). The roles of Tir and intimin are vital for the pathogenicity of REPEC 0103 (rabbit
EPEC), and C. rodentium (8). The study of rabbit EPEC serotype O103:H2 explained that
Tir and intimin are required for REPEC to nucleate F-actin and cause A/E lesions (8).
However, Tir is not necessary for A/E lesion formation, suggesting the induction of colonic
hyperplasia in mice or intestinal colonization (8).
A C. rodentium Tir mutant that expresses either EHEC Tir or TirY471F can
colonize in the mouse intestine and induce colonic hyperplasia (8). TirY471F is a mutant
strain of C. rodentium Tir ( tir + C. rodentium tir Y471F) (8). DBS100Δtir phenotype
infecting mice is analogous to the intimin deletion mutant DBS100Δeae in mouse
colonization studies (8). The delta sign (Δ) indicates the gene Δtir or Δeae is missing.
Intimin rather than Tir acts as the elicitor for inflammation, and causes colonic hyperplasia
in mice infected with shown by W. Deng et al. (8). Tir continues to serve as the receptor
in bacterial attachment for intimin so that the strain can connect to the mouse epithelial cell
surface to induce inflammatory response (8).
The Interactions between Intimin and Tir
The interactions between intimin and Tir are essential for bacterial adherence via
large bowel-colonizing A/E pathogens, but not small bowel-colonizing A/E pathogens (8).
In addition, interactions between intimin and Tir are the major pathways for colonic
adherence of EHEC and C. rodentium (8). However, intimin mutants of small bowel-
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colonizing A/E pathogens can retain their capability to colonize the host gastrointestinal
tract, which implies that intimin is likely to be responsible for initial bacterial adherence
(8). An intimin mutant implies that intimin was deleted within C. rodentium. However,
intimin’s interaction with Tir seems to be the main mechanism for colonic adhesion by
EHEC and C. rodentium (8). Wanyin Deng et al. have shown that sequence analysis
demonstrated that Citrobacter Tir is more comparable to EPEC Tir than EHEC Tir since
both Citrobacter Tir and EPEC Tir have phosphorylated tyrosine residues and can support
pedestal formation, unlike EHEC Tir (8). EHEC Tir is not tyrosine phosphorylated, and
cannot supplement EPEC or C. rodentium without the protein Tir for pedestal formation
(8).
Immune Responses
The immune responses of the intestinal mucosa play a vital role in antimicrobial
immunity and mucosal homeostasis (4). The myeloid differentiation primary response
protein 88 (MYD88) is essential in innate immune signaling downstream of the Toll-like
receptor (TLR) and the interleukin-1 receptor (IL1R), which mutually control
transcriptional regulation of multiple immune-related genes (4). MYD88 regulates C.
rodentium infection by recruiting neutrophils, macrophages, and dendritic cells to the
mucosa by expressing the inducible nitric oxide synthase (iNOS) and generating the
proliferation of epithelial cell, thus inducing colonic hyperplasia (4).
Deficient MYD88 mice lose the ability to limit bacterial replication within the host
(4). The primary donors to MYD88-mediated responses against C. rodentium are two
specific TLRs, TLR2 and TLR4, along with the whole TLR family at large as well as IL1R
are the primary donors to MYD88- mediated responses against C. rodentium (4). TLR2
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and TLR4 control C. rodentium infection by producing the pro-inflammatory cytokines,
keratinocyte chemoattractant, tumor necrosis factor (TNF), and interleukin-6 (IL-6), and
by causing upregulation of iNOS (4). TNF is the pro-inflammatory cytokines keratinocyte
chemoattractant, during C. rodentium infection in TLR-2 deficient mice, fatal colonic
pathology takes place with increased weight loss and mortality (4). TLR4 is vital for
infiltration of the intestinal mucosa by neutrophils, macrophages, and for chemokine
responses (4). TLR4 expression enhances colonization of the colon by C. rodentium during
the initial stages of infection, which indicates that low-level inflammation is beneficial for
the pathogen (4).
History of Intimin and Commensal E. coli
The most common cause of infantile diarrhea in industrialized countries during the
1940s and 1950s was EPEC, but now outbreaks are very rare (8). Previous studies have
found that classical EPEC is the most common bacterial cause of diarrhea in children who
are younger than 2 years old in non-industrialized countries (8). EPEC strains can be
grouped as typical or atypical (9). Typical EPEC strains have a virulence plasmid including
genes encoding the bundle-forming pilus (Bfp), which is needed for localizing adherence
on cultured epithelial cells (9). Atypical EPEC strains do not have the EAF plasmid with
the bfp gene (9). However, in industrialized countries, atypical EPEC strains are more
regularly isolated from diarrheal cases than typical EPEC (9). While the actual cause of
diarrhea remains undetermined, host responses to EPEC infection rather than the strain
itself likely lead to diarrhea (10).
Intimin is involved in facilitating both tissue tropism, host specificity, and provides
essential information on the association of EPEC and Shiga-toxin producing E. coli (STEC)
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with specific bacterium-host related diseases (8). Countries such as Brazil, Bangladesh,
Chile, and Uruguay have demonstrated a lower frequency of typical EPEC serotypes in
stools from children with diarrhea (8). Since C. rodentium is similar to EPEC, and has been
shown to be a useful murine model for studying gastrointestinal disease, current studies are
being done to study colonization and pathogenesis (8). The intimin gene (eae) is essential
to understanding colonization because diarrhea illness is a major public health problem
worldwide (9). Statistics have shown that over 2 million people die each year due to
diarrheal disease, especially infants younger than five years old (9).
Commensal Relationship of Enteropathogenic E. coli (EPEC) and
Enterohaemorrhagic E. coli (EHEC)
EPEC and EHEC O157:H7 within the mouse gastrointestinal tract have
characteristics similar to commensal interaction instead of pathogenic interaction (12).
Mice are used to study intestinal responses to EPEC infection and the role of virulence
factors in EPEC-induced disease since the mouse gastrointestinal tract is similar to that of
a human (12).
The Commensal E. coli 1917 Nissle was used as a control in this study to compare
colonization dynamics of EPEC, EHEC, and C. rodentium (12). Nissle was used because
the commensal has been shown to have the greatest stability in competitive fitness when
colonizing in mice (12). EHEC can colonize more efficiently and cause greater intestinal
inflammation than EPEC, which is unable to colonize effectively (12).
Understanding Quantitative Polymerase Chain Reactions
Polymerase chain reaction (PCR) amplifies a specific DNA fragment from a
convoluted pool of DNA (13). Performing PCR can be done using source DNA from a
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various tissues and organisms, including hair, skin, peripheral blood, saliva, and microbes
(13). Only picograms of DNA are required for PCR to create ample copies to be analyzed
using standard laboratory procedures (13). Since only small amount of DNA are required,
PCR is a sensitive assay (13).
Quantitative PCR (qPCR) gives information beyond the plain detection of DNA
(13). It determines how much of a specific DNA or gene is present in a given sample. qPCR
enables both the detection and quantification of the PCR product in real time, while it is
being produced (13). Two conventional methods are used to detect and quantify the qPCR
product (13). The first method is the use of fluorescent dyes that non-specifically
interpolate with double-stranded DNA (13). The second method is the use of sequencespecific DNA probes, which consists of fluorescently labeled reports (13). Analysis of
qPCR can be used to quantify the amount of a particular gene isolated, and investigate
single cells and quantify various combinations of DNA, mRNA’s, proteins (13).
Advantages of qPCR provide a simple way in understanding changes in gene
expression levels in microbes, tumors, or other disease states (13). Additionally, qPCR
produce results rapidly, and quantitatively demonstrate how much of a particular sequence
is present (13).
Recent Studies
Studies on Pretreatment with Probiotics
Probiotics are useful in preventing and treating acute diarrhea caused by
antimicrobial resistant intestinal pathogens (4). Probiotics are nonpathogenic, living
microorganisms that create beneficial health effects, often from the capability to occupy a
particular nutritional niche (14, 15). K.C. Johnson-Henry et al focused on the pretreatment
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with probiotics for mice infected with C. rodentium (14). Mice were given sterile water,
followed by 109 CFU/ml probiotics in sterile drinking water, and then followed by
maltodextrin in sterile water (14). It was found that mice given sustainable probiotics or
that were pretreated with probiotics remained in good health (14). However, mice without
pretreatment of probiotics were highly susceptible to infection with C. rodentium.
Probiotics decrease the severity of gastroenteritis in mice infected with C. rodentium (14).
Therefore, probiotics are useful in lowering the extent of infectious diarrhea and reducing
the fecal shedding of pathogens (16). There is a need for additional research in using
probiotics for outbreaks of EHEC infection in humans (14).
Probiotics are useful in interrupting enteric infectious disease progression and are
sufficient therapies for several human intestinal diseases such as infectious diarrhea,
irritable bowel disease, and enterocolitis in premature newborns (16). Additionally,
probiotics prevent binding of C. rodentium to host epithelial cells when provided before or
at the time of infection (16).
In the Johnson-Henry study, pretreatment with any particular species for three or
six hours before infection did not decrease the severity of infection (14). However,
Lactobacillus rhamnosus and Lactobacillus helveticus are probiotic mixtures that prevent
C. rodentium infection in neonatal mice (14). Resta-Lenert and Barrett showed that a
probiotic mixture of Streptococcus thermophilus and L. acidophilus mitigates the
unfavorable effects of enteroinvasive E. coli on host epithelial cells (14).
Other studies have shown the bactericidal effects of probiotics against pathogenic
bacteria (14). Probiotic treatment of epithelial cells inhibits rearrangements of host
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cytoskeletal proteins, inhibiting attaching-effacing lesions following EPEC and EHEC
infection (14).
C. rodentium Infection Studies Using Polyunsaturated Fatty Acids (PUFAs)
Dietary oils such as polyunsaturated fatty acids (PUFAs) are known to increase
susceptibility to C. rodentium infection and induce colitis (4). Omega-6 PUFA is common
in diet and an essential fatty acid (4). Dietary supplementation with omega-6 PUFA showed
increased levels of Enterobacteriaceae, Clostridium species, and segmented filamentous
bacteria (SFB) in mice, all of which have caused pro-inflammatory responses and irritable
bowel disease (4). SFB is the first example of a commensal species that alters host adaptive
immune cell homeostasis (17). Both omega-3 PUFA and omega-6 PUFA are precursors to
various substances in the body and help regulate blood pressure, and inflammatory
responses (4).

Conversely, combining omega-6 PUFA with the omega-3 PUFA

supplement increases the quantity of Lactobacillus and Bifidobacteria species but reduced
the pro-inflammatory response in the microbiota during C. rodentium infection (4).
C. rodentium Infection Studies Using Deficient Antioxidants, Selenium and Vitamin
E
Selenium and Vitamin E are antioxidants that have been shown to increase C.
rodentium infection (2). In addition, mice fed with vitamin E and selenium deficient diet
for 6 weeks had enhanced loads of C. rodentium in the spleen and colon (2). C. rodentium
was found to be an effective inducer of a Th1/Th17-type inflammatory response (2). A
greater inflammatory response was demonstrated in increased cytokine and chemokine
expression in infected mice fed the vitamin E and selenium deficient diet in comparison to
those fed a controlled diet (2).
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Vitamin E and selenium are essential in immune function and host antioxidant
defense (2). Selenium is important for controlling oxidative stress and the oxidation
balance (2). In addition, selenium is essential for protection against endotoxin-induced
oxidative stress, respiratory bursts, and cytotoxic T-lymphocyte and natural killer cell
activity (2).
Vitamin E is a potent peroxyl radical scavenger that stops lipid peroxidation and is
found to increase immune cell concentrations (2). The result of vitamin E deficiency is
increased oxidative stress and damaged immune function (2). Understanding other
methods used to increase the pathogenicity of C. rodentium infection is essential to
revealing the mechanism of the pathogenesis of C. rodentium (2, 18, 19).
Future Research Studies
Future studies on the intimin gene (eae) may aid in understanding how vital
attachment is to pathogenicity and colonization (20, 21). With C. rodentium eae (intimin
deletion mutant), attachment can be further analyzed on a new level. Another possible
future study would be using qPCR to quantify bacterial population abundances in mice
when co-colonized with C. rodentium and one of the three strains of E. coli: MG1655, HS,
and Nissle. The degrees of pathogenicity differ for each E. coli strain (22). Since MG1655
is a commensal strain, the degree of pathogenicity will be higher compared to the probiotic,
Nissle, and the normal flora, HS strain (22). Future experiments should be performed with
C. rodentium eae and E. coli to further understand their role in competitive colonic
colonization in mice. The interactions of C. rodentium through intimin along with the
interactions of C. rodentium with E. coli and probiotics should be further analyzed.
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Determining whether C. rodentium can co-colonize with E. coli strains MG1655, HS, and
Nissle will show competitive fitness patterns in the mice gastrointestinal tract.
METHODS
Experiment 1: Co-colonization of C. rodentium versus E. coli strains MG1655,
Nissle, and HS
Antibiotic Treatment and Liquid Media. Eleven CD-1 male mice, 6 weeks of age, were
given drinking water containing streptomycin sulfate (5g/L) for 24 hours prior to
inoculation as well as throughout colonization, which opens the facultative anaerobic niche
for streptomycin resistant E. coli and C. rodentium by removing the resident facultative
microbiota while leaving anaerobic microbiota essentially intact. Nalidixic acid resistant
E. coli strains and rifampicin resistant C. rodentium strains were used; appropriate
antibiotics (50ug/ml each) were used in post-infection analysis to distinguish between the
bacteria during the co-colonization. All strains were streptomycin resistant in addition to
their distinguishing antibiotic resistances. A 1% tryptone lysogeny broth was used as a
bacterial growth medium for fecal collections. MacConkey agar with appropriate
antibiotics was used as a differential growth medium to select for the desired gram-negative
antibiotic-resistant strains.
Starvation and Inoculation of Mice. Eleven CD-1 male mice were starved 24 hours prior
to inoculation to induce sufficient appetite for voluntary ingestion of bacterial suspension.
The inoculate was composed of the bacterial culture of either the C. rodentium strain or E.
coli strains suspended in the sucrose solution. A load of 105 CFU/mL was designated
feeding high, while a load of 108 CFU/mL was designated feeding low.
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Co-colonization of 9 CD-1 Mice. C. rodentium versus E. coli strains MG1655, HS, and
Nissle 1917 strains of E. coli were fed in a 105 CFU/ml bacterial suspension to 6 mice. The
remaining 2 mice were used as the control and were inoculated with C. rodentium DBS100.
Ten days post-inoculation, E. coli mice were few (low or high) DBS100 to induce
competition. The addition of C. rodentium induces a co-colonization because two different
strains of bacteria are competing for a single niche in the intestines of the mice. Control
mice were colonized for 15 days. Co-colonized mice were colonized for 21 days: 10 days
with E. coli and 11 days with C. rodentium competition.
Fecal Collection. Feces were collected from each mouse 5 hours, 24 hours, and every
second day thereafter throughout the course of the collection. One gram of feces from each
mouse was diluted in 10mL of 1% Tryptone and homogenized. Ten-fold serial dilutions
were prepared from the fecal homogenate and plated on MacConkey agar containing
appropriate antibiotics. Agar plates were incubated for 24-48 hours at 37C. The degree of
intestinal colonization of each bacteria was determined by quantifying colony forming
units persisting on the plated fecal homogenate.
CFU/gram of Feces Analysis. Colonization fitness was quantified by counting the CFU/g
of feces on each plated dilution and multiplying by the appropriate dilution factor. Strains
with the highest CFU/g of feces were considered most fit as they outcompeted other strains
for the facultative anaerobic niche in the intestine.
Fecal Genomic DNA Preparation. Fecal genomic DNA was isolated using a Qiagen DNA
Stool Mini Kit and quantified using a Thermo Scientific NanoDrop 2000
Spectrophotometer according to manufacturer’s instructions (23). The concentration of
DNA was typically around 75-300 ng/ul (23). The Qiagen DNA Stool Mini Kit provides
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the most efficient, and easy purification of total DNA from frozen or fresh stool samples
(23).
Euthanization of the Mice. All mice were euthanized on day 21 post-infection, and the
gastrointestinal tract was examined for inflammation. The colon and ceca for the mice
were weighed with feces, and without feces to observe the inflammation and hydropsy in
the gut. Fecal matter from the cecum and colon was diluted and plated as before to
determine the quantity of E. coli and C. rodentium present in the distal gastrointestinal
tract.
Experiment 2: C. rodentium eae Colonization of 3 CD-1 Male Mice Infected with C.
rodentium eae
Three CD-1 male mice were inoculated with C. rodentium eae with rifampicin
resistance using methods previously described. C. rodentium eae is a mutant version of
C. rodentium that lacks of intimin gene (eae). Since intimin facilitates bacterial attachment,
the purpose of this experiment was to observe colonization and inflammation to determine
if attachment is necessary for pathogenesis. Mice were colonized for 15 days with fecal
collections then euthanized as described previously.
Experiment 3: gDNA Community qPCR on Co-colonization Fecal Collections
qPCR samples were prepared as described by Andrew Fabich (23). Genomic DNA
from each mouse from days 7 and 17 of the co-colonization experiment were diluted to
0.5ng/mL using deionized water and prepared in a mixture containing SsoFast EvaGreen
Supermix (BioRad #172-5200) and appropriate primers as described by the Finlay study
(24). Primers for the following classifications of bacteria were included: Eubacteria,
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Bacteriodales, Bifidobacterium, Clostridium, Enterobacteriaceae and Lactobacillus (Table
1). DNA samples were taken from feces on day 7 (7 days post E. coli inoculation) and day
17 (7 days post C. rodentium inoculation) to determine how the overall bacterial population
in the gastrointestinal tract changed with the addition of a pathogenic bacterium.
Table 1. Primers for qPCR
Target 16S rRNA

Primer

Sequence

Reference

Eubacteria (total

UniF340

ACTCCTACGGGAGGCAGCAGT

(24)

bacteria)

UniR514

ATTACCGCGGCTGCTGGC

Bacterioidales

BactF285

GGTTCTGAGAGGAAGGTCCC

UniR338

GCTGCCTCCCGTAGGAGT

Bif164F

GGGTGGTAATGCCGGATG

Bif662R

CCACCGTTACACCGGGAA

Clostridium

UniF338

ACTCCTACGGGAGGCAGC

coccoides

CcocR491

GCTTCTTAGTCAGGTACCGTCAT

Enterobacteriaceae

Coli F

GTGCCAGCMGCCGCGGTAA

Coli R

GCCATAACGTTGAAAGATGG

LabF362

AGCAGTAGGGAATCTTCCA

LabR677

CACCGCTACACATGGAG

Bifidobacterium

Lactobacillus

(24)

(24)

(24)

(24)

(24)
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RESULTS

The three experiments performed aid in the understanding of C. rodentium growth
for the purpose of further understanding of human infection. E. coli commensal strain
MG1655 outcompeted C. rodentium infectious strain DBS100 in the mouse intestine. We
found MG1655 is the best E. coli strain to use during co-colonization with C. rodentium
because it shows maximal inflammation in the gastrointestinal wall in mice (Fig. 1b). Since
C. rodentium infection in mice is analogous to E. coli infection in humans, it is used as an
important model when studying gastroenteritis. However, Nissle also showed high
competitive fitness during co-colonization because the colony forming units per gram of
feces remained relatively higher throughout the course of infection (Fig. 5). The intimin
mutant data showed that the cecum had minimal inflammation during colonization with an
intimin mutant, showing that attachment plays an important role in pathogenesis (Fig. 8).
Co-colonization for C. rodentium and E. coli
Post-euthanization, the colon and ceca of all 9 mice were harvested from the mice
and weighed. Larger ceca may indicate hydropsy or swelling (Fig. 1). Control mice showed
no inflammation (a), Nissle and HS mice showed minimal inflammation (c and d), and
MG1655 mice showed the most inflammation (Fig. 1). Figure 2 consists of the CFU/g feces
analysis on the bacterial load during this 21-day experiment. E. coli HS had the greatest
bacterial load for co-colonization in comparison to E. coli Nissle and E. coli MG1655 in
competition with DBS100. Figure 3 showed the mice weights throughout the experiment.
Post-infection, the weights of all 9 CD-1 male mice infected with DBS100 and MG1655,
HS, and Nissle increased. While weights increased a minimal degree, post E. coli infection,
the more substantial increase occurred post DBS100 infection; thus, the weight increase
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was primarily due to infection by the pathogenic bacterium (Fig. 3). The weight increase
may imply swelling and hydropsy as a result of infection (Fig. 3). Figures 4 and 5
demonstrates the ceca weights with feces and the bacterial plate counts of the ceca after
euthanization. MG1655 showed the greatest competitive fitness in the cecum throughout
infection, as demonstrated by consistency in the bacterial load (Fig. 5).
C. rodentium eae Colonization
The weights remained consistent throughout the course of the colonization,
implying that the mice appeared to remain relatively healthy throughout the infection (Fig.
6). Figure 7 shows the bacterial load of the C. rodentium intimin mutant mice, which
remained fairly constant throughout the course of the infection. Figure 8 and Figure 9
compare the ceca weights with feces and without feces for all three mice as well as the
CFU’s from the ceca post-euthanization. Mouse 2 had the largest cecum and the greatest
bacterial accumulation in the gastrointestinal tract in comparison to mouse 1 and mouse 3
(data not shown). All mice exhibited negligible inflammation, implying that attachment
may be necessary for pathogenesis (data not shown).
gDNA Community qPCR for Co-colonized mice with strains C. rodentium and E. coli
MG1655, Nissle, and HS
Competitive inhibition occurs when two bacteria compete for the same unique
nutrients. The introduction of a novel bacterial species after successful colonization will
illicit competition in the enteric biome. The qPCR for this experiment is indicated in table
2 and figure 10. Between day 7 and day 17 (7 days post C. rodentium infection), there was
6.72 and 6.82 fold change in Lactobacillus and Clostridium, respectively (Fig. 10, Table
2). This suggests that during competition between two bacterial populations, competition
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will increase amongst Lactobacillus and Clostridium. Furthermore, Bifidobacterium and
Bacterioidales show very little to no enteric competitive increase versus C. rodentium
throughout the course of infection (Fig. 10). E. coli and C. rodentium are in the family of
Enterobacteriaceae, therefore, a slight increase in that category will be expected with
infection (Fig. 10).
Co-Colonization for C. rodentium and E. coli Data

C. rodentium only (control) (a)

C. rodentium + E. coli Nissle (c)

C. rodentium + E. coli MG1655 (b)

C. rodentium + E. coli HS (d)

Figure 1. Colon and Cecum length and observed inflammation. C. rodentium only mice
(a) exhibited less inflammation than co-colonized mice (b), (c), and (d). This suggests that
when there is competition between bacterial populations in the intestine, the inflammation
is greater.
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Figure 2. Bacterial load for co-colonization (C. rodentium DBS100 versus E. coli
strains) and single colonization (E. coli). E. coli MG1655 mice (b), HS (c), and Nissle

INTIMIN VERSUS E. COLI

26

(d) outcompeted C. rodentium DBS100 in the mouse intestine. MG1655 mice showed
greater fitness than E. coli HS and E. coli Nissle in competition with C. rodentium DBS100
as noted by the two-fold increase of CFU/g of feces.

Figure 3. Co-colonized mice weights. Mouse weights increased over the course of
infection, possibly due to increased water retention. The drop at day 11 is due to starvation
24 hours prior to inoculation.
1.8
1.6

Weight (grams)

1.4
1.2
CR only

1

CR + MG1655

0.8
0.6

CR + Nissle

0.4

CR + HS

0.2
0
CR only

CR +
MG1655

CR +
Nissle

CR + HS

Figure 4. Ceca weights of mice co-colonized with E. coli strains and C. rodentium. HS
E. coli strain showed greater ceca weight than the MG1655 and Nissle strains, possibly due
to inflammation, hydropsy, or increased bacterial load.
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12

Log(CFU-g feces)

10
8
MG1655 Str Nal

6

Nissle Str Nal
4

HS Str Nal

2
0
MG1655 Str Nissle Str Nal HS Str Nal
Nal

Figure 5. Ceca plate counts for co-colonized E. coli mice. Of the three E. coli strains
used, MG1655 showed greatest competitive fitness, as exhibited by the greatest bacterial
load.
C. rodentium eae Colonization Data

Figure 6. Weights for mice colonized with C. rodentium eae. Mice infected with C.
rodentium eae exhibited consistent weight throughout the colonization. This implies that
the mice remained in good health throughout the course of colonization. The increase at
day 1 is due to weight loss caused by the starvation protocol used for inoculation.
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Figure 7. Bacterial load for mice colonized with C. rodentium eae

Figure 8. Comparison of cecum with and without feces for the 3 mice infected with C.
rodentium eae.
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Figure 9. Ceca Plate Count for mice colonized with C. rodentium eae. Mouse 2 has
the highest colonization of C. rodentium eae. Mouse 1 has the lowest C. rodentium
accumulation in the gastrointestinal tract.
gDNA Community qPCR Data
Table 2. Enteric Population Fold Changes Overtime for mice Co-colonize with strains C.
rodentium and E. coli MG1655, Nissle, and HS.

Enteric Population Fold Changes Over Time
D7

D17

Lactobacillus

1.190793 ± 0.2145

8.000056 ± 0.1255

Clostridium

1.244915 ± 0.1566

8.486400 ± 0.0889

Bifidobacterium

0.000023 ± 0.0000

0.000001 ± 0.0000

Bacterioidales

0.000017± 0.0000

0.000107 ± 0.0000

Enterobacteriaceae

0.159952± 0.0281

1.092600 ± 0.0893
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D17
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Clostrid.
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Entero.

Figure 10. Enteric Population Changes Overtime for Co-colonized mice with strains
C. rodentium and E. coli MG1655, Nissle, and HS. Once C. rodentium is introduced on
Day 10 to the mice gastrointestinal tract, Lactobacillus and Clostridium show the greatest
competitive increase, as indicated by the large fold change.
DISCUSSION
The goal of this study was to understand and quantify bacterial population
abundances in the intestinal microbiome of C. rodentium and E. coli infected mice. The
long-term goal of applying the results is to aid in clinical practice and disease prevention.
Nine mice were infected with three different strain of E. coli: MG1655, HS, and Nissle.
MG1655 is a commensal lab strain, HS is a probiotic, and Nissle is a normal flora strain.
The mice were subsequently co-colonized with C. rodentium strain DBS100, a murine
pathogenic strain. The purpose of the co-colonization was (1) to determine the colonization
fitness of the various strains and (2) to observe the effects of competition on the
pathogenesis of DBS100. Unexpectedly, in each case, the E. coli strain outcompeted C.
rodentium DBS100 (Fig. 2). This is putatively due to the colonization advantage given to
the E. coli in the seven days prior to the DBS100 infection. Of the 3 E. coli strains used,
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MG1655 showed the greatest fitness, as determined by the highest quantity of colony
forming units. Following the addition of DBS100, mouse weights increased (Fig. 3). This
increase is likely a result of inflammation and water retention; inflammation was shown
upon euthanization of the mice (Fig. 3). This data implies that competition may instigate
amplified pathogenesis (Fig. 5).
It was hypothesized that performing a colonization with an intimin mutant will
show that C. rodentium induces minimal inflammation in the mouse intestine in the
absence of intimin (its primary attachment protein). Three mice infected with bacteria
lacking intimin showed negligible inflammation, which implies that attachment is
necessary for pathogenesis. The results show that intimin is likely used to cause disease
during competition with E. coli. C. rodentium is the best mouse model to use for infection
and pathogenesis investigations of E. coli to develop cures for humans infected with
gastroenteritis. Additionally, results showed that without intimin, minimal inflammation
occurs in the mouse cecum, thus supporting my hypothesis that attachment is important in
pathogenesis.
qPCR determined how much of a specific DNA or gene is present in a given sample.
qPCR enabled both the detection and quantification of the PCR product in real time, while
it is being produced. It can be inferred that at day 17 post infection (i.e. day 7 post C.
rodentium infection), enteric competition is increased. The enteric competition of
Lactobacillus and Clostridium are higher at day 7 post C. rodentium introduction (day 17
total) relative to day 7 post E. coli infection (Fig. 10). Both Lactobacillus and Clostridium
show an eight-fold increase (Lactobacillus Day 7: 1.1908 Day 17: 8.0001) (Clostridium
Day 7: 1.2449 Day 17: 8.464) from day 7 to day 17 (Table 2, Fig. 10). This is of interest
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since both Lactobacillus and Clostridium are used as probiotics to lessen or inhibit C.
rodentium infection. Thus, increase in the normal flora population of these bacteria may
indicate competition to fight off infection. Further investigations of the mechanisms and
behaviors of these bacteria in response to C. rodentium infection may aid in the
development of preventative and therapeutic treatments.
Future work needs to be done to make any statistical conclusions for the qPCR
study in relation to pathogenesis. However, these studies add to the studies investigated in
the scientific community such as the Finlay study with antibiotic treatment altering
intestinal microbiota infection (24). In order to develop cures or treatments for
gastrointestinal diseases, it is important to understand the mechanisms behind infection.
qPCR results imply that Lactobacillus and Clostridium are effective enteric competitors,
suggesting that can be used to antagonistically treat bacterial infections with C. rodentium
and E. coli.
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